• Deutsch
    • English
  • Deutsch 
    • Deutsch
    • English
  • Einloggen
Dokumentanzeige 
  •   Startseite
  • Naturwissenschaften, Mathematik und Informatik
  • Fakultät für Physik (inkl. GAUSS)
  • Dokumentanzeige
  •   Startseite
  • Naturwissenschaften, Mathematik und Informatik
  • Fakultät für Physik (inkl. GAUSS)
  • Dokumentanzeige
JavaScript is disabled for your browser. Some features of this site may not work without it.

3D Virtual Histopathology by Multiscale X-Ray Phase-Contrast Tomography: Novel Tools and Applications

von Jakob Reichmann
Dissertation
Datum der mündl. Prüfung:2024-07-05
Erschienen:2025-07-02
Betreuer:Prof. Dr. Tim Salditt
Gutachter:Prof. Dr. Tim Salditt
Gutachter:Prof. Dr. Sarah Köster
crossref-logoZum Verlinken/Zitieren: http://dx.doi.org/10.53846/goediss-11314

 

 

Dateien

Name:diss_comp_noCV.pdf
Size:73.1Mb
Format:PDF
Description:Doctoral Thesis
ViewOpen

Lizenzbestimmungen:


Zusammenfassung

Englisch

Histological analysis has been considered as the gold standard for studying tissue architecture for over two centuries, providing essential insights into tissue morphology and organization. However, the technique is inherently destructive and limited to the microscopic visualization of two-dimensional sections. In recent years, X-ray phase-contrast computed tomography (XPCT) has emerged as a promising non-destructive imaging modality which can bridge the gap between classical histology and volumetric imaging, enabling virtual 3D histology of intact tissues on multiple length scales. In this thesis, we explore the potential of XPCT as a tool for morphometric analysis and three-dimensional tissue characterization, with applications in neuroscience, pathology, and preclinical studies. The first section introduces the fundamentals of X-ray imaging, phase contrast formation and quantitative analysis. The second section investigates whether Neodymium acetate is suitable as a new staining agent for enhanced contrast in XPCT. In section three, XPCT is used to study a variety of neurodegenerative disease hallmarks in human brain tissue. The fourth section evaluates lung imaging, focusing on physiological and pathological features. In section five, whole-organ imaging of human placentae is addressed, with a focus on vasculature segmentation and three-dimensional tissue visualization across several length scales. Finally, section six demonstrates XPCT’s scalability for laboratory, high-throughput imaging in preclinical models of SARS-CoV-2 infection in combination with morphometric tissue analysis. Combining advanced optics, phase retrieval algorithms, and morphometric analysis, this work establishes XPCT as a viable, non-destructive alternative to traditional histology, offering high-resolution 3D visualization of tissue morphology.
Keywords: X-ray phase-contrast imaging; tissue analysis; tissue morphology; 3D histology; multiscale imaging
 

Statistik

Hier veröffentlichen

Blättern

Im gesamten BestandFakultäten & ProgrammeErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTypIn dieser FakultätErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTyp

Hilfe & Info

Publizieren auf eDissPDF erstellenVertragsbedingungenHäufige Fragen

Kontakt | Impressum | Cookie-Einwilligung | Datenschutzerklärung | Barrierefreiheit
eDiss - SUB Göttingen (Zentralbibliothek)
Platz der Göttinger Sieben 1
Mo - Fr 10:00 – 12:00 h


Tel.: +49 (0)551 39-27809 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
ediss_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]
Niedersächsische Staats- und Universitätsbibliothek | Georg-August Universität
Bereichsbibliothek Medizin (Nur für Promovierende der Medizinischen Fakultät)
Robert-Koch-Str. 40
Mon – Fri 8:00 – 24:00 h
Sat - Sun 8:00 – 22:00 h
Holidays 10:00 – 20:00 h
Tel.: +49 551 39-8395 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
bbmed_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]